Bracco Imaging S.p.A., a global leader in diagnostic imaging, and Subtle Medical, Inc., a pioneering innovator in artificial intelligence (AI)-powered image acquisition, announced today that AiMIFY™, their jointly developed AI-powered software for magnetic resonance imaging (MRI) of the brain, has received the CE (Conformité Européenne) Mark under the European Medical Device Regulation (MDR).

At ECR 2025, Bracco reaffirmed its commitment to innovation and sustainability in radiology with two major developments aimed at enhancing contrast media efficiency and reducing environmental impact.

At the Japanese World Expo, to be held from April 13 to October 13, 2025, the Bracco Group will be a key contributor on the themes of art, technology and medicine of the future.

EuSoMII/Bracco together for the 2025 AI Contest

Bracco@ECR2025, Our journey to the future continues today, together. For a sustainable tomorrow.

Bracco Imaging announced today that the U.S. FDA has granted Fast Track designation for the development of BR55 (perfluorobutane/nitrogen lipopeptide-coated microbubbles) injection for detecting areas of active bowel inflammation in patients with Crohn's disease.

We’re excited to announce the integration of the ACIST commercial organization into Bracco Imaging. Starting this January, ACIST products in France, Germany, and Benelux will be distributed through Bracco affiliates, unifying operations under the OneBracco strategy.

We are pleased to invite you to join an educational webinar entitled Effective Gadolinium Reduction with the New High- Relaxivity Gadopiclenol in CNS scheduled for January 15 from 6:00 to 7:00 pm CET.

EuSoMII/Bracco together for the 2025 AI Contest

Over 80 million euros has been invested to build Hexagon, a new manufacturing facility located next to the historical 1996 plant which will, when fully operational, triple the production and distribution of one of the leading products from Bracco's research.

Bracco Imaging is delighted to announce that Gadopiclenol (marketed as Vueway^® by Bracco) has been honored with the JFR 2024 Innovation Award in the Jury's Favorite category.

This webinar series, in collaboration with Springer Healthcare Italia, a global leader in healthcare education and communication, is designed to provide radiologists with practical insights into the use of innovative digital tools and technologies to improve the effectiveness of medical writing.

Mr. Campione brings more than 25 years global experience in successful development and commercialization of diagnostic imaging agents and radiopharmaceuticals.

The Bracco Group announces its direct presence in the Japanese market, where it has been doing business since 1990 through a successful joint venture with Eisai

Vueway^®, a new macrocyclic gadolinium-based contrast agent for CE-MRI, received Marketing Authorisation in the European Union By European Commission.

During the conference “Sustainability, growth, employment: The Torviscosa model,” Bracco announced the plan to expand production capacity at its Torviscosa plant to meet the increasing demand for X-ray contrast agents, and will be making new hires

During the conference "Sustainability, growth, employment: the Torviscosa model,” the Bracco Group presented its new Sustainability Report. The Report enumerates all the actions that Bracco, global leader in diagnostic imaging, has taken in favour of people, the planet and innovation.

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended approval of the macrocyclic, high-relaxivity Gadopiclenol in adults and pediatric patients older than 2 years of age.

Diana Bracco: “Artificial Intelligence will assist radiologists in making increasingly accurate and reliable diagnoses”

Re.Viva works to capture and redeploy used substances in the positive momentum of the circular economy: the Bracco Iodine Recollection Pilot

The company, founded in 1927 and today one of global leader in imaging diagnostics, joins in the select club of companies that represent the spearhead of our Made in Italy that enhance the image of Italy in the world.

Bracco will acquire all shares of Bracco-Eisai held by Eisai and change its name from Bracco-Eisai to Bracco Japan, Ltd.  as of April 1, 2023.

Bracco’s standpoint on sustainability - and environmental sustainability in particular - is that it is essential to look at the full picture.

The UN Global Compact is a call to companies everywhere to align their operations and strategies with ten universally accepted principles in the areas of human rights, labour, environment and anti-corruption.

We are thrilled to open the doors of our “digital house” created by our people and inhabited by our stories

Alberto Spinazzi, Bracco Chief Medical and Regulatory Officer, answers some of these questions by illustrating future trends and the importance of prevention for human health.

The multimedia installation explaining the importance of diagnostic imaging is now on display at STEP, to relate the future of radiology and precision medicine

Talking Images podcast: The sustainable way – voices of action. What do environmental sustainability and sustainable future mean?

BIPSO sets the course for sterile contrast media production according to the latest environmental standards.

The astounding Bracco story unfolds across archives that have been thematically divided into five sections: Family, Company, Innovation, Sustainability, and Culture.

95 grants to celebrate Bracco’s 95th Anniversary

The US shortage crisis: Bracco Imaging’s CEO statement on New York Times

A new customised nanomedicine project to fight cancer, a new therapy that includes pre-treating

They have left the war in Ukraine behind and have been welcomed in Italy by the Bracco Group in collaboration with the Town of Cesano and the local community.

Shaharzad Akbar arrived from Rome where she had provided testimony during a meeting of Italy’s Chamber of Deputies and Senate Joint Committee on Foreign Affairs.

Some of the goals in a Policy Paper drafted by the B20 Special Initiative on Women’s Empowerment.

Trieste Next Festival: Diana Bracco and Gianvito Vilé talk about scientific research and the brain drain.

The Bracco Foundation: ten years in the name of culture, science and social engagement.

The two companies announced the launch of a study to reduce contrast media in wastewater through sustainable urine filtration systems for hospitals and diagnostic facilities.

This strategic partnership is set to explore the development of next-generation acoustic microspheres, a groundbreaking alternative to conventional magnetic beads for rare and complex cell sorting and separation in flow-based applications.

Industry Leaders to Explore the Potential of AI in Contrast-Enhanced MRI.

Bracco Imaging and Arrayus Technologies have partnered to improve drug delivery for pancreatic cancer using focused ultrasound and microbubble technology.

Innovative Collaboration to Enhance Ischemic Stroke Detection and Patient Care, Elevating Standards in Diagnostic Imaging.

The collaboration focuses on combining Verasonics' Vantage^®️ NXT Research Ultrasound Systems with Bracco's contrast agents to explore improved imaging performance in various research applications.

Samsung Medison and Bracco Imaging endorsed a Memorandum of Understanding agreement to pioneer a new area for diagnostic ultrasound device and contrast agent at European Congress of Radiology 2024 held in Vienna, Austria on February 28^th to March 3^rd.

The partnership will bring a Bracco branded state of the art MR injector to the United States under an exclusive private label arrangement.